Cargando...
Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes
In type 1 diabetes (T1D), pancreatic beta-cells are attacked and destroyed by the immune system, which leads to a loss of endogenous insulin secretion. The desirable outcome of therapeutic intervention in autoimmune diseases is the restoration of immune tolerance to prevent organ damage. Past trials...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SBDR - Society for Biomedical Diabetes Research
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3740700/ https://ncbi.nlm.nih.gov/pubmed/23804270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2012.9.328 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|